trending Market Intelligence /marketintelligence/en/news-insights/trending/ZKCgyL0V9i_V-6UVghji2w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

ConvaTec lowers sales growth expectations on supply issues

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


ConvaTec lowers sales growth expectations on supply issues

Convatec Group Plc revised its sales growth expectations, citing supply issues in two of its business segments and lower than anticipated revenue contribution from new products.

The company — which made headlines as London's largest IPO in 2016 — now anticipates full-year organic revenue growth of between 1% and 2%, down from 4% previously.

Convatec Group made limited progress in fulfilling backorders in the advanced wound care business segment due to delays with logistics, including hurricanes disrupting shipping lanes in the Caribbean.

The company moved its manufacturing lines from Greensboro in the U.S. to Haina in the Dominican Republic, which also caused some delays in securing regulatory approvals. The same was also true for the movement of the final two manufacturing lines in the ostomy care business segment.

Convatec said it had lost some business due to the build-up of backorders, which it is addressing and expects to resolve by the end of the fourth quarter.

Convatec shares were down to £2.05 as of market close on Oct. 16, the day the company revised its sales expectations. The company's stock closed at £2.793 on Oct. 13, the last business day before the announcement was made.